Siegfried Holding AG (SFZN) – Strategy, SWOT and Corporate Finance Report

Siegfried Holding AG (SFZN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Siegfried Holding AG (Siegfried) is a life science company. It is active in the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients (APIs). It manufactures APIs for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company offers a comprehensive range of services to its partners including registration and manufacturing to packaging and logistics. It also offers development and production services for finished dosage forms including sterile filling. Siegfried has production facilities in the US, Switzerland, Malta, China, Germany, Spain and France. The company also offers its products in the US, Europe, and other countries. Siegfried is headquartered in Zofingen, Aargau, Switzerland.

Scope

• Detailed information on Siegfried Holding AG required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Siegfried Holding AG in the form of a SWOT analysis

• An in-depth view of the business model of Siegfried Holding AG including a breakdown and examination of key business segments

• News about Siegfried Holding AG, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Siegfried Holding AG and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Siegfried Holding AG as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Siegfried Holding AGs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Lonza Group Ltd

IBR Inc

Bachem Holding AG

Perrigo Co Plc

Corden Pharma Switzerland LLC

Jetpharma SA

Legacy Pharmaceuticals Switzerland GmbH

Corden Pharma Switzerland LLC

Jetpharma SA

IBR Inc

Lonza Group Ltd

Bachem Holding AG

Perrigo Co Plc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Siegfried Holding AG - Key Facts

Siegfried Holding AG - Key Employees

Siegfried Holding AG - Key Employee Biographies

Siegfried Holding AG - Major Products and Services

Siegfried Holding AG - History

Siegfried Holding AG - Company Statement

Siegfried Holding AG - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Siegfried Holding AG - Business Description

Product Category: Drug Products

Overview

Performance

Product Category: Drug Substances

Overview

Performance

Geographical Segment: Europe (excluding Switzerland)

Performance

Geographical Segment: Switzerland

Performance

Geographical Segment: US

Performance

R&D Overview

Siegfried Holding AG - Corporate Strategy

Siegfried Holding AG - SWOT Analysis

SWOT Analysis - Overview

Siegfried Holding AG - Strengths

Siegfried Holding AG - Weaknesses

Siegfried Holding AG - Opportunities

Siegfried Holding AG - Threats

Siegfried Holding AG - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Siegfried Holding AG, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 09, 2023: Siegfried opens global Development Center for Drug Products in Barcelona

Feb 22, 2023: Siegfried significantly increases sales and profits in 2022

Feb 18, 2023: Siegfried appoints Christian Dowdeswell as chief business officer drug substances

Aug 24, 2022: Siegfried begins building a large production facility in Minden

Apr 13, 2022: Siegfried Announces appointment of two new board members

Feb 23, 2022: Siegfried achieves sales of more than one billion for the first time and increases profitability

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Siegfried Holding AG, Key Facts

Siegfried Holding AG, Key Employees

Siegfried Holding AG, Key Employee Biographies

Siegfried Holding AG, Major Products and Services

Siegfried Holding AG, History

Siegfried Holding AG, Subsidiaries

Siegfried Holding AG, Joint Venture

Siegfried Holding AG, Key Competitors

Siegfried Holding AG, Ratios based on current share price

Siegfried Holding AG, Annual Ratios

Siegfried Holding AG, Annual Ratios (Cont…1)

Siegfried Holding AG, Annual Ratios (Cont…2)

Siegfried Holding AG, Interim Ratios

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Siegfried Holding AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Siegfried Holding AG, Performance Chart (2018 – 2022)

Siegfried Holding AG, Ratio Charts

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports